- Filed
- Mar 16, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Mar 11, 2026 | 8.34M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 8.34M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 8.34M sh |
| Shares Diluted restated | Q3 2026 · Jan 31, 2025 | 8.34M sh |
| Shares Diluted restated | Q3 2026 · Jan 31, 2025 | 8.34M sh |
| Operating Cash Flow | Q3 2026 · Jan 31, 2026 | $386.09K |
| Operating Cash Flow | Q3 2026 · Jan 31, 2025 | −$286.36K |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | $1.85M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | $1.9M |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | $1.86M |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | $1.91M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | $1.11M |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | $1.03M |
| Stockholders Equity | Q3 2026 · Jul 31, 2024 | $1M |
| Stockholders Equity | Q3 2026 · Apr 30, 2024 | $1.06M |
| Current Liabilities | Q3 2026 · Jan 31, 2026 | $457.98K |
| Current Liabilities | Q3 2026 · Apr 30, 2025 | $347.57K |
| Total Liabilities | Q3 2026 · Jan 31, 2026 | $457.98K |
| Total Liabilities | Q3 2026 · Apr 30, 2025 | $347.57K |
| Current Assets | Q3 2026 · Jan 31, 2026 | $2.31M |
| Current Assets | Q3 2026 · Apr 30, 2025 | $2.26M |
| Total Assets | Q3 2026 · Jan 31, 2026 | $2.31M |
| Total Assets | Q3 2026 · Apr 30, 2025 | $2.26M |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | −$0.01 |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | −$0.01 |
| Eps Diluted restated | Q3 2026 · Jan 31, 2025 | $0.01 |
| Eps Diluted restated | Q3 2026 · Jan 31, 2025 | $0.01 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | −$0.01 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | −$0.01 |
| Eps Basic restated | Q3 2026 · Jan 31, 2025 | $0.01 |
| Eps Basic restated | Q3 2026 · Jan 31, 2025 | $0.01 |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $219.6K |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $405.34K |
| Sga Expense | Q3 2026 · Jan 31, 2025 | $30.67K |
| Sga Expense | Q3 2026 · Jan 31, 2025 | $128.35K |
| Net Income | Q3 2026 · Jan 31, 2026 | −$44.36K |
| Net Income | Q3 2026 · Jan 31, 2026 | −$54.85K |
| Net Income | Q3 2026 · Oct 31, 2025 | $35.81K |
| Net Income | Q3 2026 · Jul 31, 2025 | −$46.3K |
| Net Income | Q3 2026 · Jan 31, 2025 | $72.98K |
| Net Income | Q3 2026 · Jan 31, 2025 | $50.41K |
| Net Income | Q3 2026 · Oct 31, 2024 | $32.65K |
| Net Income | Q3 2026 · Jul 31, 2024 | −$55.21K |
| Operating Income | Q3 2026 · Jan 31, 2026 | $46.73K |
| Operating Income | Q3 2026 · Jan 31, 2026 | $113.46K |
| Operating Income | Q3 2026 · Jan 31, 2025 | $108.87K |
| Operating Income | Q3 2026 · Jan 31, 2025 | $126.06K |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $316.34K |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $645.93K |
| Gross Profit | Q3 2026 · Jan 31, 2025 | $189.31K |
| Gross Profit | Q3 2026 · Jan 31, 2025 | $418.32K |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $393.28K |
| Cost Of Revenue | Q3 2026 · Jan 31, 2026 | $594.71K |
| Cost Of Revenue | Q3 2026 · Jan 31, 2025 | $119.01K |
| Cost Of Revenue | Q3 2026 · Jan 31, 2025 | $290.59K |
| Revenue | Q3 2026 · Jan 31, 2026 | $709.63K |
| Revenue | Q3 2026 · Jan 31, 2026 | $1.24M |
| Revenue | Q3 2026 · Jan 31, 2025 | $308.32K |
| Revenue | Q3 2026 · Jan 31, 2025 | $708.91K |